{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:31:15Z","timestamp":1771270275385,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,4,16]],"date-time":"2011-04-16T00:00:00Z","timestamp":1302912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pompe disease is an orphan disease for which enzyme replacement therapy (ERT) recently became available. This study aims to estimate all relevant aspects of burden of illness\u2014societal costs, use of home care and informal care, productivity losses, and losses in health\u2010related quality of life (HRQoL)\u2014for adult Pompe patients only receiving supportive care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected data on all relevant aspects of burden of illness via a questionnaire. We applied a societal perspective in calculating costs. The EQ\u20105D was used to estimate HRQoL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty adult patients (87% of the total Dutch adult Pompe population) completed a questionnaire. Disease severity ranged from mild to severe. Total annual costs were estimated at \u20ac22,475 (range \u20ac0\u2013169,539) per adult Pompe patient. Patients on average received 8 h of home care and 19 h of informal care per week. Eighty\u2010five percent of the patients received informal care from one or more caregivers; 40% had stopped working due to their disease; another 20% had reduced their working hours. HRQoL for Pompe patients who only received supportive care was estimated at 0.72, 17% lower than the Dutch population at large.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Adult Pompe disease is associated with a considerable burden of illness at both the societal and patient levels. The disease leads to substantial costs and dependency on medical devices, home care, and informal care, and has a high impact on the patient's social network. In addition, patients are limited in their ability to work and have significantly reduced HRQoL.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10545-011-9320-x","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T06:34:35Z","timestamp":1302849275000},"page":"1045-1052","source":"Crossref","is-referenced-by-count":29,"title":["Burden of illness of Pompe disease in patients only receiving supportive care"],"prefix":"10.1002","volume":"34","author":[{"given":"Tim A.","family":"Kanters","sequence":"first","affiliation":[{"name":"Department of Health Policy &amp; Management, Institute for Medical Technology Assessment Erasmus University Rotterdam Rotterdam The Netherlands"},{"name":"Center for Lysosomal and Metabolic Diseases Erasmus MC University Medical Center Rotterdam The Netherlands"},{"name":"Institute for Medical Technology Assessment Erasmus University Rotterdam P.O. Box 1738 Burgemeester Oudlaan 50 Rotterdam 3000 DR The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes L. C.","family":"Hagemans","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases Erasmus MC University Medical Center Rotterdam The Netherlands"},{"name":"Department of Pediatrics, Division of Metabolic Diseases and Genetics Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine A. M. E.","family":"van der Beek","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases Erasmus MC University Medical Center Rotterdam The Netherlands"},{"name":"Department of Neurology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans F. H.","family":"Rutten","sequence":"additional","affiliation":[{"name":"Department of Health Policy &amp; Management, Institute for Medical Technology Assessment Erasmus University Rotterdam Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[{"name":"Center for Lysosomal and Metabolic Diseases Erasmus MC University Medical Center Rotterdam The Netherlands"},{"name":"Department of Pediatrics, Division of Metabolic Diseases and Genetics Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona","family":"Hakkaart","sequence":"additional","affiliation":[{"name":"Department of Health Policy &amp; Management, Institute for Medical Technology Assessment Erasmus University Rotterdam Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,4,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200367"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"e_1_2_8_4_1","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond MF","year":"2004"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462305050221"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462307051550"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_8_8_1","first-page":"S118","article-title":"Cost\u2010of\u2010illness of rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"Franke LC","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-007-9237-x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142597.69707.78"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000165979.46537.56"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.03.018"},{"key":"e_1_2_8_13_1","volume-title":"Pharmacotherapeutic compass","year":"2009"},{"key":"e_1_2_8_14_1","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease","author":"Hirschhorn R","year":"2001"},{"key":"e_1_2_8_15_1","unstructured":"HoogendoornEJI FeenstraTL Rutten\u2010van M\u00f6lkenMPMH(2004)Inventarization health care usage and costs for asthma and COPD in the Netherlands (in Dutch).RIVM Bilthoven."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101183440304"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.11.033"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000251268.41188.04"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-006-0378-6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(94)00044-5"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.8.1122"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1124"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"e_1_2_8_25_1","volume-title":"Manual for cost analysis, methods and standard unit costs for economic evaluations in health care","author":"Oostenbrink JB","year":"2004"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808314962"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_2_8_28_1","first-page":"153","volume-title":"Proceedings of the 24th scientific plenary meeting of the EuroQol Group","author":"Stolk EA","year":"2009"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.117150"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02533-2"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.2.332"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61555-X"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909859"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-011-9320-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:09:07Z","timestamp":1694812147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-011-9320-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,16]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1007\/s10545-011-9320-x"],"URL":"https:\/\/doi.org\/10.1007\/s10545-011-9320-x","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,16]]}}}